Blockade of the renin–angiotensin–aldosterone system

Steven M. Shaw, John E. Macdonald and Simon G. Williams

in Chronic Heart Failure

Published on behalf of Oxford University Press

Published in print October 2008 | ISBN: 9780199542338
Published online May 2011 | e-ISBN: 9780191740053 | DOI:

Series: Oxford Cardiology Library

Blockade of the renin–angiotensin–aldosterone system

More Like This

Show all results sharing this subject:

  • Cardiovascular Medicine


Show Summary Details


Blockade of the renin–angiotensin–aldosterone system is a cornerstone of treatment of patients with chronic heart failure (CHF).

The use of angiotensin-converting enzyme (ACE) inhibitors in patients with CHF improves quality of life and prognosis across all stages of the disorder.

The angiotensin receptor blockers are effective substitutes for ACE inhibitors.

The combination of ACE inhibitors and angiotensin-receptor blockers is effective in reducing mortality and morbidity in patients with CHF.

Spironolactone an aldosterone antagonist is effective in patients with more advanced heart failure; evidence in less severely symptomatic heart failure is awaited.

Chapter.  2092 words.  Illustrated.

Subjects: Cardiovascular Medicine

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content. subscribe or purchase to access all content.